LEADER 01150oam  2200361   450 
001 9910707813203321
005 20170109150700.0
035   $a(CKB)5470000002468430
035   $a(OCoLC)967939077
035   $a(EXLCZ)995470000002468430
100   $a20170109d2016      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aScleroderma (2016)
210  1$aBethesda, MD :$cNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Information Clearinghouse, National Institutes of Health,$d2016.
215   $a1 online resource (19 pages)
225 1 $aNIH publication ;$vno. 16-4271
225 1 $aHandout on health
300   $a"August 2016."
517   $aScleroderma 
606   $aScleroderma (Disease)
615  0$aScleroderma (Disease)
712 02$aNational Arthritis and Musculoskeletal and Skin Diseases Information Clearinghouse (U.S.),
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910707813203321
996   $aScleroderma (2016)$93298799
997   $aUNINA